What are the Financial Barriers to Technological Innovation?
The development of new cancer technologies is often hindered by financial constraints. Research and development in this field require substantial investment, and funding is not always readily available. High costs associated with clinical trials, regulatory approval, and market entry can deter innovation. Additionally, the reimbursement landscape for new technologies is often uncertain, making it challenging for companies to recoup their investments.
